Relmada Therapeutics logo
Relmada Therapeutics RLMD
$ 0.37 5.5%

Quarterly report 2024-Q3
added 11-07-2024

report update icon

Relmada Therapeutics Interest Expense 2011-2024 | RLMD

Annual Interest Expense Relmada Therapeutics

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
5.15 M 2.66 M 1.2 M 1.4 M 104 K -1.34 M 932 K 13.2 M 4.92 K - 220 K 27.7 K -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
13.2 M -1.34 M 2.15 M

Quarterly Interest Expense Relmada Therapeutics

2024-Q3 2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1
- - - - 1.32 M 1.36 M 1.21 M - 828 K 387 K 330 K - 298 K 323 K 420 K - 363 K 404 K 408 K - 37.9 K - 15.9 K -140 K -650 K -790 K -652 K 29.2 K -830 28.4 K 301 K 506 K -24 K 506 K -24 K 1.17 K 1.64 K 2.81 K 125 1.1 K 3.27 K 1.1 K 3.27 K 112 K 67 K - 29.4 K - - - - - - - -

All numbers in USD currency

Indicator range from quarterly reporting

Maximum Minimum Average
1.36 M -790 K 190 K